Alembic Pharma gets USFDA nod for Alembic Pharma

The approved product is therapeutically equivalent to AstraZeneca Pharmaceuticals' Xylocaine ointment, 5 per cent.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news